Symbol="SLN"
AssetType="Common Stock"
Name="Silence Therapeutics PLC"
Description="Silence Therapeutics plc, a biotechnology company, is focused on the discovery and development of new ribonucleic acid (RNA) therapies in hematology, cardiovascular, and other rare and metabolic indications. The company is headquartered in London, the United Kingdom."
CIK="1479615"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="72 HAMMERSMITH ROAD, LONDON, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="244853000"
EBITDA="-51089000"
PERatio="None"
PEGRatio="None"
BookValue="0.614"
DividendPerShare="0"
DividendYield="0"
EPS="-1.51"
RevenuePerShareTTM="0.544"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-4.18"
RevenueTTM="23153000"
GrossProfitTTM="6621000"
DilutedEPSTTM="-1.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.988"
AnalystTargetPrice="39.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="31.67"
PriceToBookRatio="12.79"
EVToRevenue="14.87"
EVToEBITDA="-5.56"
Beta="0.768"
num_52WeekHigh="17.99"
num_52WeekLow="4.545"
num_50DayMovingAverage="5.93"
num_200DayMovingAverage="9.53"
SharesOutstanding="35954900"
DividendDate="None"
ExDividendDate="None"
symbol="SLN"
open="6.70"
high="7.00"
low="6.63"
price="6.99"
volume="6862.00"
latest_trading_day="2023-08-18"
previous_close="6.81"
change="0.18"
change_percent="2.6432%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="80"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="67924"
Change_recent_avg="-0.02"
Delta_recent_avg="0.66"
Variance_recent_avg="0.33"
Change_ratio_recent_avg="-0.62"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="1141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_negative_thumbnail_id_2="105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="984"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_positive_thumbnail_id_2="602"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0106.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
